drugset / Trial / NCT06752486
Assessment of Safety and Efficacy of Gabapentin After Surface Ablation, a Case Control Experimental Study
RandomizedParallel-groupOpen-labelTreatment
Summary
The current study aims at assessing the efficacy and safety of oral Gabapentin alone versus Diclofenac Potassium drugs for postoperative analgesia in patients undergoing surface ablation.
Timeline
- Start
- 2024-12-01
- Primary completion
- 2025-05-10
- Completion
- 2025-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Diclofenac | Other / unclassified | 50 mg | Oral |
| Comparator | Gabapentin | Small molecule | 300 mg | Oral |
Indications
No indication recorded.